A. Brochot

发表

Full-length de novo assembly of RNA-seq data in pea (Pisum sativum L.) provides a gene expression atlas and gives insights into root nodulation in this species.

P. Wincker, J. Gouzy, C. Cruaud, 2015, The Plant journal : for cell and molecular biology.

Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy.

A. Brochot, A. Stockis, M. Zamacona, 2010, Basic & clinical pharmacology & toxicology.

Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir.

A. Brochot, T. van de Casteele, T. Kakuda, 2014, The Journal of antimicrobial chemotherapy.

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged ≥3 to <12 Years

A. Brochot, T. van de Casteele, A. Vermeulen, 2015, CPT: pharmacometrics & systems pharmacology.

Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial

K. Tashima, A. Brochot, T. van de Casteele, 2014, AIDS Research and Therapy.

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV‐1‐Infected, Treatment‐Experienced Children and Adolescents in PIANO

A. Brochot, T. Kakuda, R. Hoetelmans, 2016, Journal of clinical pharmacology.

Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine

A. Brochot, H. Crauwels, T. Kakuda, 2017, Clinical Pharmacokinetics.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Pea in the genomic era

Susete Alves Carvalho, P. Wincker, J. Gouzy, 2015 .

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)

N Holford, AC Hooker, K Ogungbenro, 2017, CPT: pharmacometrics & systems pharmacology.

Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects

D. Huntjens, A. Brochot, S. Ouwerkerk-Mahadevan, 2017, Clinical Pharmacokinetics.

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults

K. Tashima, A. Brochot, T. Kakuda, 2014, Journal of the International AIDS Society.

Model based dosing rationale for darunavir when co-administered with low-dose ritonavir in pediatric HIV-1 infected patients

A. Brochot, A. Vermeulen, T. Kakuda, 2013 .